The urotoxicity of cyclophosphamide and the protective effect of the herb b
erberine were investigated in this study Administration of 150 mg/kg cyclop
hosphamide intraperitoneally caused a serious haemorrhagic cystitis in rats
after 12 hr, including bladder oedema, haemorrhage, and dramatic elevation
of nitric oxide metabolites (nitrite+nitrate) in urine and in plasma. To e
xplore whether cyclophosphamide-induced cystitis could be prevented by berb
erine, rats were pretreated with a single dose or two doses of berberine at
50, l00, or 200 mg/kg intraperitoneally then challenged with cyclophospham
ide (150 mg/kg, intraperitoneally). The results indicated that pretreatment
of rats with berberine could reduce cyclophosphamide-induced cystitis in a
dose-dependent manner. Furthermore, we found that two doses of berberine s
howed greater protection against cyclophosphamide urotoxicity than when giv
en a single dose. In addition, our data shows that a single dose of 200 mg/
kg berberine, or two doses of 100, and 200 mg/kg berberine could completely
block cyclophosphamide-induced bladder oedema and haemorrhage as well as n
itric oxide metabolites increase in rat urine and plasma. In conclusion, ou
r findings suggest that berberine could be a potential effective drug in th
e treatment of cyclophosphamide-induced cystitis, and provides us with the
bright hope in the prevention and treatment of cyclophosphamide urotoxicity
.